MHRA (UK) now also a full ICH Member
Recommendation
27/28 May 2025
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
Register now for ECA's GMP Newsletter
The United Kingdom (UK) becomes a full member of three international associations. In addition to the International Medical Device Regulatory Forum (IMDRF) and the US-based Medical Devices Innovation Consortium (MDIC), now also in the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Before leaving the EU ("Brexit"), the MHRA was a member of both the IMDRF and the ICH under the EU system, became an observer state after Brexit and is now a sovereign full member.
Dr Glenn Wells, Chief International and Partnerships Officer at MHRA, commented:
"We are pleased to be working with these three international organisations on regulatory alignment that will help ensure safer, innovative and more cost-effective medicines and medical devices get to the people who need them faster".
Source: MHRA press release
Related GMP News
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review
23.04.2025New WHO Guideline Package: TRS 1060 published
16.04.2025EMA: QPs must provide a written final Assessment and Approval of Third-Party Audit Reports
15.04.2025Strategic Report published by the Critical Medicines Alliance
09.04.2025EMA's Plans for the next three Years